Multi-Institutional Study Data Presented at ASTRO 2023 Builds Upon Growing Evidence of GammaTile for Patients with Brain Tumors
Imaging Technology
OCTOBER 3, 2023
christine.book Tue, 10/03/2023 - 11:37 October 3, 2023 — Medical device company GT Medical Technologies, Inc. announced interim findings of a multi-institutional study that demonstrates high local control for the treatment of recurrent brain metastases in patients. The findings add to the growing evidence of the efficacy and safety of its FDA-approved GammaTile Therapy, and were presented during an Oct. 2 poster presentation at the American Society for Radiation Oncology's (ASTRO) 65th Annual Me
Let's personalize your content